YC W21
Serna Bio
Genetic Medicine with Small Molecules
About
Serna Bio is developing small molecules to modulate RNA function, unlocking the potential to treat diseases driven by biology intractable by other modalities.
Founder
Family Office Investors
Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Serna Bio.
See family office activityIndustry & Focus
HealthcareTherapeuticsBiotechDrug discovery